Affiliation:
1. Federal State Budgetary Institution «National Medical Research Center for Preventive Medicine» of the Ministry of Healthcare of the Russian Federation
Abstract
The review analyzes data on the safety of apixaban for the prevention of thromboembolic complications in patients with nonvalvular atrial fibrillation and venous thromboembolic complications obtained in randomized controlled studies.
Reference27 articles.
1. Kirchhof P., BenusSi S., Kotecha D., et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. The task Force for the management of atrial fibrillation of the european society of Cardiology (ESC). Developed with the special contribution of the european Heart Rhythm Association (EHRA) of the ESC. endorsed by the european stroke organisation (ESO). Eur Heart J. 2016; 50: e1-e88.
2. Steffel J., Verhamme P., Potpara T.S., et al. The 2018 european Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation. Europace. 2018; 39: 1330-1393.
3. Konstantinides S., Torbicki A., Agnelli G., et al. 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism. the task Force for the Diagnosis and Management of Acute Pulmonary embolism of the european society of Cardiology (ESC). endorsed by the european Respiratory society (ERS). Eur Heart J. 2014; 35: 3033-3069.
4. Kearon C., Akl E.A., Ornelas J., et al. Antithrombotic therapy for VTE Disease. Chest Guideline and expert Panel Report. Chest. 2016; 149: 315-352.
5. Hsu J.C., Maddox T.M., Kennedy K.F., et al. Oral Anticoagulant therapy Prescription in Patients with Atrial Fibrillation Across the spectrum of stroke Risk Insights from the NCDR PINNACLE Registry. JAMA Cardiol. 2016; 1: 55-62.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献